AcquisitionsThe BioVectra acquisition will expand its CDMO services offering in higher-growth segments and enable a more complete gene editing solution.
Financial PerformanceAgilent's EPS of $1.32 beat expectations by 5%, showing strong financial performance.
Market ActivitySigns of stability in A's China revenue run-rate, which grew on improved service/consumables demand, reflecting solid underlying lab activity in the region.